IL15 and neoplasm: As shown in Supplementary Fig. 17b–d, the biNV-IL-15 displayed the excellent capability of tumor recurrence inhibition in contrast to IL-15:IL-15Rα and IL-15:IL-15Rα+biNV, resulting in superior survival outcomes.